Scientists Find Link between CFS and XMRV


Scientists Find Link between CFS and XMRV

According to a new study, the scientists have found a link between chronic fatigue syndrome (CFS) patients and the Xenotropic Murine Leukemia Virus-related Virus (XMRV).

XMRV is similar to HIV and was discovered in the year 2006. The virus is relatively unknown in the medical world.

Following the new study, the Australian Red Cross Blood Service has decided to temporarily suspend donations from CFS sufferers.

Once more, studies will be conducted on XMRV and the Red Cross will review its decision within two years.

The XMRV studies were conducted by the Whittemore Peterson Institute for Neuro-Immune Disease and it was found that around 67% patients suffering from CFS tested positive for the retrovirus.

The findings could be helpful in understanding CFS, which affects as many as 180,000 people in Australia.

The diagnosis of CFS varies from one patient to another patient, because of different severity level.

According to a CFS/ME Working Group, less than 10% of patients recover completely from the disease. The recovery is rare in those patients, who are suffering from the disease for more than five years.

Presently, Queensland’s Bond University is doing a three-year study into CFS and the researchers are hopeful that a faster diagnosis method will be developed.

Latest News

Deutsche Bank Q3 Loss may be a Record One in a Decade
Volkswagen Scandal Worries the City of Wolfsburg
Strong Component Sale and Weak Won help Samsung’s Third Quarter Profits
Is the U.S. Shale Oil Boom Heading Towards the Beginning of Its End?
Volkswagen Plans to Launch a Recall in January and Fix the Affected Diesel Cars
BOJ Keep Record Stimulus Unchanged
BP Plc will Pay $20 Billion as Penalties for the Deadly Oil Spill of 2010
Ben Bernanke says Larger Number of Executives Involved in 2008 Financial Crisis
United’s New CEO Oscar Muñoz Aims at Improving relation with Workers
The September Job Number Hint at a Sluggish Patch
First Data Launches its IPO, Targets to Raise Up to $3.7 Billion
ConAgra’s Head Quarter Move Announcement gets Positive but ‘Muted’